ACCURAMED BIOTECHNOLOGY LIMITED

AccuraMed Biotechnology Limited, founded in 2016 and owned by Biostar Technology Limited, is a high-tech company specializing in tissue biomarker detection and analysis. They provide innovative tumor drug target research and advanced immunodiagnostic testing solutions, focusing on the tumor immune microenvironment for clinical and basic research. AccuraMed has established partnerships with top institutions, such as the Chinese Academy of Sciences, and operates labs in Guangzhou and Hong Kong.

AccuraMed, founded in 2016 and owned by Biostar Technology Limited, is a high-tech company specialising in the detection and analysis of tissue biological markers. The company is dedicated to advancing tumour immunity research through innovative tumour drug target discovery and the development of clinical and pathological immunodiagnostic testing solutions. AccuraMed provides advanced analysis of the tumour tissue immune microenvironment, supporting both clinical and basic scientific research. They have strong partnerships with the Chinese Academy of Sciences, leading universities, hospitals, and biotech enterprises.

AccuraMed Biotechnology Limited, founded in 2016 and owned by Biostar Technology Limited, is a high-tech company specialising in tissue biomarker detection and analysis. They provide innovative tumour drug target research and advanced immunodiagnostic testing solutions, focusing on the tumour immune microenvironment for both clinical and basic research. AccuraMed has established partnerships with leading institutions, such as the Chinese Academy of Sciences, and operates laboratories in Guangzhou and Hong Kong.